Automated spiral plate counter produces accurate clinical trial results in tests on acne and other conditions at the Skin Research Centre of the University of Leeds
Synbiosis says its Protocol automated colony counter is being successfully used by the world renowned Skin Research Centre (SRC) at the University of Leeds to rapidly test the effectiveness of new therapies to treat acne and other skin diseases.
SRC chose Protocol because it is flexible enough to quickly generate precise, GLP compliant, automated spiral plate counts of propionibacteria, staphylococcim, and the yeast Malassezia furfur, (micro-organisms associated with skin diseases) from a variety of selective media.
These counts are then used to determine which treatments are reducing the number of organisms on the skin of those on the trial.
Richard Bojar, senior research scientist at SRC commented: "The Protocol is an excellent system.
As well as producing fast, accurate counts of skin micro-organisms, it also records every detail of the sample including a plate image, plus date and time, all of which can be printed as a report.
This is essential for making the external MCA audit of our trial results a much simpler process." Simon Johns, international product manager for Synbiosis added: "We are delighted that the Protocol is being used to help evaluate new drugs for skin conditions.
Its ability to safely store and easily retrieve documentary evidence that a drug is effective makes it highly applicable for use in clinical trials of anti-infective therapies being developed by both pharmaceutical and biotechnology companies."
